ABCL vs JNJ: Which Stock is Better?
Side-by-side comparison of Abcellera Biologics Inc and Johnson & Johnson in 2026
ABCL
Abcellera Biologics Inc
—
JNJ
Johnson & Johnson
$232.77
Key Metrics Comparison
| Metric | ABCL | JNJ | Winner |
|---|---|---|---|
| Market Cap | $1.12B | $375.37B | JNJ |
| P/E Ratio | N/A | 17.35 | JNJ |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze ABCL
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ABCL or JNJ a better investment?
Comparing ABCL and JNJ: Abcellera Biologics Inc has a market cap of $1.12B while Johnson & Johnson has $375.37B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ABCL and JNJ?
ABCL (Abcellera Biologics Inc) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ABCL or JNJ?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ABCL or JNJ?
Both ABCL and JNJ show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: ABCL or JNJ?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: ABCL or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $375.37B compared to $1.12B for ABCL.
Should I buy ABCL or JNJ in 2026?
Both ABCL and JNJ have investment merit. ABCL trades at $N/A while JNJ trades at $232.77. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ABCL and JNJ stock?
Key differences: Market Cap ($1.12B vs $375.37B), P/E Ratio (N/A vs 17.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy ABCL or JNJ in 2026?
The choice between ABCL and JNJ depends on your investment goals. JNJ shows higher revenue growth (0.0%). JNJ has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between ABCL and JNJ?
ABCL (Abcellera Biologics Inc) has a market cap of $1.12B, while JNJ (Johnson & Johnson) has a market cap of $375.37B. JNJ is the larger company by market value.